|
|
Name: |
Blue Owl Capital Holdings LP |
City: |
New York |
State: |
NY |
Zip: |
10022 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
29 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
PLRX |
Pliant Therapeutics, Inc. |
1 |
New |
$0.00 |
$54,406,000 |
3,004,199 |
13.01% |
54,406,000 |
3,004,199 |
4.776 |
N/A |
|
CGEM |
Cullinan Oncology Ord Shs |
3 |
New |
$0.00 |
$34,848,000 |
3,419,842 |
8.33% |
34,848,000 |
3,419,842 |
7.858 |
N/A |
|
TRML |
Tourmaline Bio |
4 |
New |
$0.00 |
$32,394,000 |
1,332,302 |
7.74% |
32,394,000 |
1,332,302 |
3.225 |
N/A |
|
RPTX |
Repare Therapeutics Inc. |
7 |
New |
$0.00 |
$22,794,000 |
3,122,499 |
5.45% |
22,794,000 |
3,122,499 |
8.497 |
N/A |
|
SLRN |
Acelyrin, Inc. |
8 |
New |
$4.73 |
$17,106,000 |
2,292,990 |
4.09% |
17,106,000 |
2,292,990 |
2.359 |
N/A |
|
LRMR |
Larimar Therapeutics Inc |
9 |
New |
$1.15 |
$15,536,000 |
3,414,468 |
3.71% |
15,536,000 |
3,414,468 |
8.549 |
N/A |
|
KROS |
Keros Therapeutics, Inc. |
10 |
New |
$0.00 |
$14,021,000 |
352,633 |
3.35% |
14,021,000 |
352,633 |
1.038 |
N/A |
|
RARE |
Ultragenyx Pharmaceutical Inc |
11 |
New |
$40.97 |
$12,588,000 |
263,238 |
3.01% |
12,588,000 |
263,238 |
0.386 |
Restaurants |
|
ENGN |
Engene Holdings Inc. |
12 |
New |
$14.24 |
$11,397,000 |
1,234,760 |
2.72% |
11,397,000 |
1,234,760 |
5.322 |
N/A |
|
SYRS |
Syros Pharmaceuticals, Inc. |
13 |
New |
$5.43 |
$8,463,000 |
1,493,252 |
2.02% |
8,463,000 |
1,493,252 |
2.657 |
N/A |
|
IRON |
Disc Medicine, Inc |
14 |
New |
$31.84 |
$8,101,000 |
140,260 |
1.94% |
8,101,000 |
140,260 |
0.806 |
N/A |
|
BPMC |
Blueprint Medicines Corp |
16 |
New |
$105.46 |
$6,631,000 |
71,888 |
1.59% |
6,631,000 |
71,888 |
0.109 |
N/A |
|
INZY |
Inozyme Pharma, Inc. |
18 |
New |
$0.00 |
$5,410,000 |
1,270,027 |
1.29% |
5,410,000 |
1,270,027 |
2.056 |
N/A |
|
MLYS |
Mineralys Therapeutics, Inc. |
19 |
New |
$0.00 |
$4,888,000 |
568,379 |
1.17% |
4,888,000 |
568,379 |
1.391 |
N/A |
|
CMPX |
Compass Therapeutics Ord Shs |
20 |
New |
$0.00 |
$4,414,000 |
2,829,712 |
1.06% |
4,414,000 |
2,829,712 |
2.887 |
N/A |
|
MLTX |
Multisys Language Solutions... |
21 |
New |
$0.00 |
$3,925,000 |
65,000 |
0.94% |
3,925,000 |
65,000 |
0.158 |
N/A |
|
IKNA |
Ikena Oncology, Inc. |
22 |
New |
$0.00 |
$3,849,000 |
1,953,616 |
0.92% |
3,849,000 |
1,953,616 |
6.486 |
N/A |
|
LABD |
Direxion Daily S&p Biotech ... |
23 |
New |
$8.06 |
$3,295,000 |
340,000 |
0.79% |
3,295,000 |
340,000 |
1.176 |
N/A |
|
OMGA |
Omega Therapeutics, Inc. |
24 |
New |
$2.36 |
$3,178,000 |
1,055,882 |
0.76% |
3,178,000 |
1,055,882 |
2.002 |
N/A |
|
OVID |
Ovid Therapeutics Inc. |
25 |
New |
$3.23 |
$2,785,000 |
864,822 |
0.67% |
2,785,000 |
864,822 |
1.363 |
N/A |
|
DELL |
Dell Technologies Inc |
26 |
New |
$134.12 |
$2,684,000 |
35,091 |
0.64% |
2,684,000 |
35,091 |
0.013 |
N/A |
|
ORTX |
Orchard Therapeutics Plc |
27 |
New |
$0.00 |
$2,631,000 |
1,599,660 |
0.63% |
2,631,000 |
1,599,660 |
8.694 |
N/A |
|
IMVT |
Immunovant Inc |
28 |
New |
$0.00 |
$2,528,000 |
60,000 |
0.6% |
2,528,000 |
60,000 |
0.069 |
N/A |
|
BDTX |
Black Diamond Therapeutics,... |
29 |
New |
$5.74 |
$1,953,000 |
695,000 |
0.47% |
1,953,000 |
695,000 |
1.931 |
N/A |
|
SGMT |
Sagimet Biosciences Inc. |
30 |
New |
$4.38 |
$1,926,000 |
355,377 |
0.46% |
1,926,000 |
355,377 |
1.664 |
N/A |
|
BRZE |
Braze, Inc. |
33 |
New |
$0.00 |
$942,000 |
17,726 |
0.23% |
942,000 |
17,726 |
0.036 |
N/A |
|
RLYB |
Rallybio Corp |
35 |
New |
$0.00 |
$837,000 |
350,240 |
0.2% |
837,000 |
350,240 |
1.015 |
N/A |
|
FRLN |
Freeline Therapeutics Hldgs |
37 |
New |
$0.00 |
$552,000 |
86,654 |
0.13% |
552,000 |
86,654 |
0.139 |
N/A |
|
DTIL |
Precision Biosciences Inc |
41 |
New |
$11.62 |
$7,367 |
20,221 |
0.05% |
221,000 |
20,221 |
0.547 |
N/A |
|